Matthew Link

CIK: 0001565950

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (60.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

FBLG

FibroBiologics, Inc.

Director

SGHT

Sight Sciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

FBLG
FibroBiologics, Inc.
Jun 23, 2026
Award(A)
Stock Option (Right to Buy)
Direct
30.8K shares-
SGHT
Sight Sciences, Inc.
Jul 2, 2025
Sale(S)
Direct
4.9K shares at avg. $4.10$20K
FBLG
FibroBiologics, Inc.
Jun 12, 2025
Award(A)
Stock Option (Right to Buy)
Direct
22K shares-
SGHT
Sight Sciences, Inc.
May 16, 2025
Award(A)
Direct
6.6K shares at avg. $3.02$20K
SGHT
Sight Sciences, Inc.
Apr 2, 2025
Sale(S)
Direct
5K shares at avg. $2.31$12K
SGHT
Sight Sciences, Inc.
Mar 11, 2025
Award(A)
Direct
172K shares-
SGHT
Sight Sciences, Inc.
Oct 21, 2024
Sale(S)
Direct
21.8K shares at avg. $5.61$122K
SGHT
Sight Sciences, Inc.
Oct 18, 2024
Sale(S)
Direct
20.5K shares at avg. $5.98$122K
SGHT
Sight Sciences, Inc.
Oct 17, 2024
Sale(S)
Direct
21K shares at avg. $5.84$122K
SGHT
Sight Sciences, Inc.
Oct 16, 2024
Sale(S)
Direct
20.7K shares at avg. $5.91$122K

		Type	Shares	Price		Ownership
Jun 23, 2026	FBLG FibroBiologics, Inc.	Award(A) Stock Option (Right to Buy)	30,803	-	-	Direct
Jul 2, 2025	SGHT Sight Sciences, Inc.	Sale(S)	4,889	$4.10	$20,035	Direct
Jun 12, 2025	FBLG FibroBiologics, Inc.	Award(A) Stock Option (Right to Buy)	22,000	-	-	Direct
May 16, 2025	SGHT Sight Sciences, Inc.	Award(A)	6,631	$3.02	$20,012	Direct
Apr 2, 2025	SGHT Sight Sciences, Inc.	Sale(S)	5,042	$2.31	$11,642	Direct
Mar 11, 2025	SGHT Sight Sciences, Inc.	Award(A)	172,043	-	-	Direct
Oct 21, 2024	SGHT Sight Sciences, Inc.	Sale(S)	21,831	$5.61	$122,450	Direct
Oct 18, 2024	SGHT Sight Sciences, Inc.	Sale(S)	20,487	$5.98	$122,451	Direct
Oct 17, 2024	SGHT Sight Sciences, Inc.	Sale(S)	20,970	$5.84	$122,444	Direct
Oct 16, 2024	SGHT Sight Sciences, Inc.	Sale(S)	20,734	$5.91	$122,434	Direct

1-10 of 10 transactions

About Link Matthew

Link Matthew (SEC CIK 0001565950) files insider reports with the SEC as Director of FibroBiologics, Inc. (FBLG) and Chief Commercial Officer of Sight Sciences, Inc. (SGHT).

Signal8 holds 9 ownership filings by Link Matthew, all Form 4s, filed between Oct 18, 2024 and Jun 23, 2026. Those filings report 10 transactions, from Oct 16, 2024 to Jun 23, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Link Matthew's filings is in HOUSTON,, TX.

Recent filings by Link Matthew

Jun 23, 2026: Grant or award of FBLG derivative securities (Form 4, code A).
Jul 2, 2025: Open-market sale of SGHT shares (Form 4, code S).
Jun 12, 2025: Grant or award of FBLG derivative securities (Form 4, code A).
May 16, 2025: Grant or award of SGHT shares (Form 4, code A).
Apr 2, 2025: Open-market sale of SGHT shares (Form 4, code S).

Other insiders filing for FibroBiologics, Inc. (FBLG)

Khoja Hamid, Chief Scientific Officer
Steinberg Leigh, Director
Rubins Kathleen Hallisey, Director
Hoffman Robert E., Director
Cilento Richard C. Jr., Director
Niklas Victoria Ninon Olivia, Director

How to read Form 4 transaction codes